Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of an investigational antitumor agent (Japan, jRCT2080222594)
jRCT2080222594Phase 1Completed
- Start
- Sep 2014
01
Overview
Phase 1 trial in cancer. Started Sep 2014; status: completed.
02
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080222594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222594.